Security key
558868105
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL)
CUSIP: 558868105
Q4 2019 13F Holders as of 31 Dec 2019
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 10,473,886
- Total 13F value
- $954,273,764
- Share change
- +716,384
- Put/Call ratio
- 1135%
- SEC-reported price per share
- $91.11
- Number of holders
- 119
- Value change
- +$65,909,446
- Number of buys
- 62
- Number of sells
- 46
- Shares outstanding
- 22,822,754
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2019
Institutions
119
Top holders
10
MDGL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2020
Previous quarter: Q3 2019
MADRIGAL PHARMACEUTICALS, INC. SEC filings
MADRIGAL PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 558868105
Recent filing periods:
Ownership snapshot
Top reported holders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
15/15
Latest evidence
30 Sep 2019
13F
Lead comparable stake: 7.4%
Showing 1-6 of 15 holder rows.
Quick read
Capital Research Global Investors leads the comparable SEC ownership view at 7.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Capital Research Global Investors
7.4%
BAKER BROS. ADVISORS LP
5.1%
HealthCor Management, L.P.
4.5%
WELLINGTON MANAGEMENT GROUP LLP
3.7%
VANGUARD GROUP INC
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
Company
|
7.4%
|
$145,131,000
1,683,269 shares
|
— | 30 Sep 2019 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
5.1%
|
$100,815,000
1,169,278 shares
|
— | 30 Sep 2019 |
| HealthCor Management, L.P. |
13F
Company
|
4.5%
|
$88,912,000
1,031,220 shares
|
— | 30 Sep 2019 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
3.7%
|
$72,610,000
842,147 shares
|
— | 30 Sep 2019 |
| VANGUARD GROUP INC |
13F
Company
|
3.5%
|
$68,108,000
789,939 shares
|
— | 30 Sep 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
2.5%
|
$49,844,000
578,098 shares
|
— | 30 Sep 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
119
Shares
10,473,886
Rows available
119
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
108
Q4 2019 holders
119
Holder diff
11
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 value | Q4 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend